The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
With the big game on the horizon, many are planning their menus for Super Bowl Sunday. But if your shopping list contains Lay ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.